TORONTO, Nov. 21, 2013 /CNW/ - Yesterday the Cancer Quality Council of
Ontario recognized outstanding achievement in cancer care by handing
out the Quality and Innovation Awards in Toronto.
The Quality and Innovation Awards are an annual event sponsored by the
Cancer Quality Council of Ontario (CQCO), Cancer Care Ontario (CCO) and
the Canadian Cancer Society, Ontario Division. Now in its eighth year,
the awards honour the development of new approaches, processes,
products, or programs that enhance and improve cancer care delivery in
Ontario. Programs or organizations awarded for quality and innovation
have demonstrated a significant impact on stakeholders, the patient
experience, cost effectiveness and sustainability for the cancer
"Each year, the Quality and Innovation Awards encourage and recognize
organizations or programs that have made significant improvements for
the delivery of quality care across the province and sparked innovation
resulting in better care for cancer patients. This year is no
exception," said Virginia McLaughlin, Chair of CQCO. "This year's award
winners and honourable mentions initiated programs that strengthen the
delivery of exceptional care and hold tremendous promise for helping
improve health outcomes."
"Ontario has one of the best cancer systems in the world, thanks in no
small part to the work of the programs and organizations honoured by
the Quality and Innovation Awards," said Deb Matthews, Minister of
Health and Long-Term Care. "I want to thank all of this year's
honourees for their tremendous work and contribution to innovation and
quality when it comes to caring for cancer patients."
"Improving quality and driving innovation are what happens when
dedicated individuals join forces to address significant challenges,"
said Michael Sherar, President and CEO, CCO. "The Quality and
Innovation Awards recognize exemplary programs that advance the cancer
system. It is these types of innovative initiatives that lead to better
quality care, which in turn have a direct and powerful impact on the
lives of patients, families and communities across Ontario."
"Through our work of supporting those living with cancer, we know how
important the delivery of quality care is to patients and their
families," said Martin Kabat, CEO, Canadian Cancer Society, Ontario
Division. "That's why the Canadian Cancer Society proudly supports the
Quality and Innovation Awards and we commend this year's recipients for
their innovative work to improve the quality of life of people touched
The 2013 CQCO Quality and Innovation Award Recipients:
Princess Margaret Cancer Centre received the Quality Award for the implementation of a Medication Reimbursement Specialist who
helps patients navigate through public and private drug insurance
procedures for financial reimbursement of costly medication received
outside of hospital. The system of reimbursement for drug costs can be
complex, frustrating and time-consuming for patients, caregivers and
healthcare providers. Assistance with securing funds for the
medications also means the start of treatment can begin earlier. Total
drug costs avoided for patients was over $2 million, averaging over
$3,700 per patient.
The Ottawa Hospital received the Innovation Award for the Ottawa Cardiac Oncology Program (OCOP) for their
multidisciplinary team consisting of medical oncology, cardiology and
pharmacy for patients undergoing cancer treatment and possible
complications such as heart damage. Established in 2008, OCOP was the
first program of its kind in Canada. OCOP provides patients with an
integrated approach to cancer therapy, with seamless communication
between healthcare providers from several medical specialties and
timely access to medical assessment and treatment services, having an
impact on quality of care post-treatment.
St. Joseph's Healthcare Hamilton and HNHB LHIN garnered a Quality Award Honourable Mention for the development of their Esophageal Diagnostic Assessment Program
(EDAP), which identifies patients requiring immediate referral for
suspected esophageal cancer. EDAP has a single access point for
referrals to reduce wait times for diagnosis, minimize repeated tests,
and improve patient experience and treatment outcomes. The EDAP has
reduced the wait time for diagnostic testing from an average of 4-6
months to 15 days. Now, average time from EDAP referral to decision to
treatment is 30 days.
Princess Margaret Cancer Centre obtained the Innovation Award Honourable Mention for its QuickStart Program which provides same-day radiotherapy for
early-stage breast cancer. Implemented in 2010, the QuickStart
initiative brings together technological advances in software with
clinical expertise to expedite scans, treatment planning and delivery
of the first treatment, all within one day. The QuickStart program is now a standard treatment option offered to
women with early-stage breast cancer.
This year's awards celebration was made possible in part by a financial
contribution from the Canadian Cancer Society, Ontario Division.
About the Cancer Quality Council of Ontario
The Cancer Quality Council of Ontario (www.cqco.ca) is an arm's length advisory group that advises Cancer Care Ontario and
the Ministry of Health and Long-Term Care in their efforts to improve
the quality of cancer care in the province. The Council also monitors
and publicly reports on the performance of the cancer system annually
via the Cancer System Quality Index www.csqi.on.ca and provides international comparisons and benchmarking to allow
Ontario to learn from other jurisdictions.
SOURCE: Cancer Quality Council of Ontario
For further information:
Cancer Care Ontario